Remote Patient Monitoring Plays Important Role
Remote Patient Monitoring Plays Important Role in Advancing Home ... unknown
Thanks to digital health solutions such as remote patient monitoring
FDA Updates for the Week of Aug. 28, 2023
FDA Updates for the Week of Aug. 28, 2023 unknown
FDA Approves Reblozyl as First-Line Treatment in MDS-Related Anemia
The
Healthcare Dealmakers—Oregon's $6.6B hospital merger and more
Healthcare Dealmakers—Oregon's $6.6B hospital merger and more unknown Healthcare Dealmakers—Oregon's $6.6B hospital
Sept. 1 - Roz Brewer steps down suddenly as Walgreens CEO
Sept. 1 - Roz Brewer steps down suddenly as Walgreens CEO PharmaVoice
Ketamine and psychedelics delivery tech in the spotlight
AION Receives FDA Clearance for Its iTempShield Skin-Wearable Device and Software Platform for Professional and Retail Environments
Technology Designed for Multiple Applications, with Initial Focus on Early Infection Detection and Treatment
August 30, 2023 07:05 AM
Reflection paper on the use of artificial intelligence in the lifecycle of medicines
News 19/07/2023
EMA has published a draft reflection paper outlining the current thinking on the use of artificial
The Telemedicine Program Design Canvas: a visual tool for planning telemedicine interventions
Oxford Open Digital Health, Volume 1, 2023, oqac002, https://doi.org/10.1093/oodh/oqac002Published: 20 December 2022
Telemedicine has
Integrating metabolic expenditure information from wearable fitness sensors into an AI-augmented automated insulin delivery system
Background
Exercise can rapidly drop glucose in people with type 1 diabetes. Ubiquitous wearable fitness sensors are not integrated into
HOW AI-POWERED DRUG DEVELOPMENT IS RESHAPING PHARMACEUTICAL RESEARCH
This is a post from the Visium Blog by Matteo Togninalli, Chief Operating Officer
Aug 28, 2023 • 12 min. read
Q2 2023 Gene Therapy Report: Promising New Treatments on the Horizon
The potential for gene therapies to treat – or even effectively cure – debilitating medical conditions continues to expand. Our latest quarterly